Integrum AB Company Description

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses.

The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket.

The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads.

The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation.

It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.

Integrum AB (publ)

Country	Sweden
Founded	1990
Industry	Medical Devices
Sector	Healthcare
Employees	39
CEO	Scott Flora

Contact Details

Address: Gemenskapens gata 9 Mölndal, 431 53 Sweden
Phone	46 3 17 60 10 60
Website	integrum.se

Stock Details

Ticker Symbol	INTEG.B
Exchange	Nasdaq Stockholm
Share Class	Class B Shares
Fiscal Year	May - April
Reporting Currency	SEK
ISIN Number	SE0009807266
SIC Code	3842

Key Executives

Name	Position
Anna-Tove Branemark	Chief Executive Officer of Integrum Inc.
Scott D. Flora	Acting Chief Executive Officer and Director
Dr. Rickard Branemark	Founder, Owner, Chief Scientific Advisor and Director
Jorgen Svanstrom	Interim Chief Finance Officer
Inger Rydin	Chief Operating Officer
Karin Ganlöv M.D.	Chief Medical Officer
Jeffrey S. Zanni	President of U.S. and Head of American Operations
Jerry Frimanson	Head of Supply